Bristol-Myers Squibb: 15-min chart signals RSI Oversold, KDJ Golden Cross.

Bristol-Myers Squibb's 15-minute chart has exhibited an oversold reading on the Relative Strength Index (RSI) and a golden cross on the KDJ indicator as of August 25, 2022, at 11:45. This suggests that the stock price has declined precipitously and is currently trading below its fundamental support level. However, the momentum indicators indicate a shift in the stock price's direction towards an uptrend, potentially paving the way for further price appreciation.

Bristol-Myers Squibb (BMY) has been showing a mixed bag of signals, with technical scores indicating caution while fundamentals and money flow suggest a positive outlook. As of August 25, 2022, at 11:45, the 15-minute chart exhibited an oversold reading on the Relative Strength Index (RSI) and a golden cross on the KDJ indicator. These technical indicators suggest a shift in the stock's direction towards an uptrend, potentially paving the way for further price appreciation.

The stock has risen 4.33% recently, but analysts are divided, with an average rating of 3.00 on a 5-point scale, reflecting neutral to bearish sentiment. The FDA's stricter drug approval policies and Regeneron's volatile performance highlight sector risks, adding to the uncertainty. Technical indicators like Bearish Engulfing and Shooting Star suggest short-term volatility, while the HHS's revised Covid-19 vaccine policy adds long-term uncertainty.

The market snapshot shows a wait-and-see stance, with institutional caution contrasting with retail buying. The overall inflow ratio is slightly positive but mixed across investor types, indicating a moderate inflow but not a surge. Big-money trends are negative, suggesting institutional investors are cautious or taking profits, while retail trends are positive, indicating retail investors are buying.

Key fundamental factors include a strong annualized ROE of 44.61%, healthy margins, and positive profitability trends. However, the stock's rich valuation and weak technical scores suggest caution. The RSI oversold reading and KDJ golden cross indicate a potential shift in momentum, but the overall weak technical score of 4.02 and bearish signals like Shooting Star suggest caution.

Investors should consider waiting for a clearer trend to emerge before entering the market. The bullish Engulfing pattern on August 22, 2025, gives some hope for a rebound, but the Shooting Star and overall weak technical score suggest caution. Watching for a breakout or breakdown in the coming weeks and considering using earnings or regulatory news as a catalyst for trade decisions would be prudent.

References:
[1] https://www.ainvest.com/news/stock-analysis-bristol-myers-squibb-outlook-mixed-bag-signals-volatility-2508/